Gene159
ADSS2: adenylosuccinate synthase 2
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. ADSS2: adenylosuccinate synthase 2. Genes, record 159. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/159
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P30520 | Adenylosuccinate synthetase isozyme 2 | 456 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents50
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260196299 A1 | 2026-07-09 | 38 | P30520 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36736 | P30520 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8069 | P30520 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 8069 | P30520 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8069 | P30520 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 2913 | P30520 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 313 | P30520 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 313 | P30520 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 36790 | P30520 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 36736 | P30520 | Espacenet |
NIH grants456
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ADSS2 papers | Newest fiscal year |
|---|---|---|---|
| R01DK046492 | Engineered Glucose Metabolism in Insulin Secreting Cells | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 3 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| R01AI125534 | Determinants of apicoplast maintenance in malaria parasites | 2 | 2025 |
| K12HD001264 | Women's Reproductive Health Research at the University of Washington | 1 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 1 | 2025 |
| P01HL131477 | Functional consequences of stem and progenitor cell heterogeneity | 1 | 2025 |
| P20GM103427 | Nebraska Research Network in Functional Genomics | 1 | 2025 |
| P20GM121176 | Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2. | 1 | 2025 |
Source NIH's project files
Papers539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics. | Nat Cancer | 2026 | 42362999 | PubTator, text mining | PubMed |
| Molecular analysis of carbapenem-resistant Acinetobacter baumannii isolated from bronchoalveolar lavage fluid in a tertiary hospital in Ningxia, China. | Front Cell Infect Microbiol | 2026 | 41884533 | PubTator, text mining | PubMed |
| The oncogenic control of nucleotide synthesis. | Oncogenesis | 2026 | 41881963 | PubTator, text mining | PubMed |
| Genomic Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand. | Antibiotics (Basel) | 2026 | 41750431 | PubTator, text mining | PubMed |
| Genetic determinants of efficacy of antiviral drugs revealed by genome-wide CRISPR screens. | Antiviral Res | 2025 | 41260510 | PubTator, text mining | PubMed |
| Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth. | Sci Rep | 2025 | 40825832 | PubTator, text mining | PubMed |
| Deciphering the molecular clock: exploring molecular mechanisms and genetic influences on skin ageing. | Biogerontology | 2025 | 40751759 | PubTator, text mining | PubMed |
| Neurokinin 1 receptor inhibition alleviated mitochondrial dysfunction via restoring purine nucleotide cycle disorder driven by substance P in acute pancreatitis. | Acta Pharm Sin B | 2025 | 40654355 | PubTator, text mining | PubMed |
| Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance. | Cell Death Dis | 2025 | 40645971 | PubTator, text mining | PubMed |
| Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells. | Diabetes | 2025 | 40638403 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/159
GET https://conductscience.org/api/genes/v1/159/patents?page=2